Procurement Summary
Country: Brazil
Summary: Price Registration for Future Purchase of Medicines. Protocol N 24.330.962-0
Deadline: 07 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 128817648
Document Ref. No.: 91687/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Price registration for future purchase of medicines. Protocol n 24.330.962-0
UASG code: 456793
Notice from: 10/24/2025 from 08:00 to 12:00 and from 13:00 to 17:00
Proposal Delivery: from 10/24/2025 at 08:00
ASCORBIC ACID, DOSAGE 200 MG/ML, ORAL SOLUTION USE TYPE
Quantity: 300
ALBENDAZOLE, DOSAGE 40 MG/ML, USE ORAL SUSPENSION
Quantity: 2600
GENTAMICIN, DOSAGE 40 MG/ML, INJECTABLE SOLUTION APPLICATION
Quantity: 27200
TOBRAMYCIN, ACTIVE INGREDIENT ASSOCIATED WITH DExAMETHASONE, DOSAGE 0.3% + 0.1%, PRESENTATION OPHTHALMIC OINTMENT
Amount : 150
GLIMEPIRIDE, DOSAGE 2 MG
Quantity: 2000
SUCRALFATE, DOSAGE 200 MG/ML, PHARMACEUTICAL FORM ORAL SUSPENSION
Quantity: 3600
LIDOCAINE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH NOREPINEPHRINE, DOSAGE 2% + 1:50, 000, INJECTABLE PRESENTATION
HYDROxIZINE HYDROCHLORIDE, CONCENTRATION 2 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION
Quantity: 1000
LOSARTAN POTASSIUM, DOSAGE 25 MG
Quantity: 4500
ONDANSETRONE HYCLORHYDRATE, DOSAGE 2 MG/ML, INJECTABLE INDICATION
Quantity: 68000
MICONAZOLE NITRATE, DOSAGE 20 MG/G, CREAM PRESENTATION
Quantity: 310
BETAMETHASONE, VALERATE COMPOSITION, CONCENTRATION 1 MG/G, PHARMACEUTICAL FORM CREAM
Quantity: 250
HYDROCORTISONE, ACETATE SALT COMPOSITION, CONCENTRATION 10 MG/G, PHARMACEUTICAL FORM CREAM
Quantity: 1200
URSODEOxICOLIC ACID, CONCENTRATION 50 MG
Amount : 3650
Documents
Tender Notice